Page last updated: 2024-11-08

tiazofurin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tiazofurin: RN given refers to (beta-D)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tiazofurine : A C-glycosyl compound that is 1,3-thiazole-4-carboxamide in which the hydrogen at position 2 has been replaced by a beta-D-ribofuranosyl group. It is metabolised to thiazole-4-carboxamide adenine dinucleotide (TAD), a selective inhibitor of inosine monophosphate dehydrogenase (IMP dehydrogenase). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID457954
CHEMBL ID108358
CHEBI ID90239
SCHEMBL ID4287
MeSH IDM0104452

Synonyms (50)

Synonym
ci-909
tiazofurine
tcar
cpd-5825
(1r)-1-[4-(aminocarbonyl)-1,3-thiazol-2-yl]-1,4-anhydro-d-ribitol
60084-10-8
2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]thiazole-4-carboxamide
2-.beta.-d-ribofuranosyl-4-thiazolecarboxamide
tiazofurin
nsc-286193
tiazofurin (usan)
tiazofurine (inn)
D06130
brn 1084555
riboxamide
tiazofurin [usan]
tiazofurina [spanish]
nsc 286193
tiazofurinum [latin]
2-beta-d-ribofuranosyl-4-thiazolecarboxamide
4-thiazolecarboxamide, 2-beta-d-ribofuranosyl-
2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide
chebi:90239 ,
CHEMBL108358
2-beta-d-ribofuranosylthiazole-4-carboxamide
AKOS016010248
bdbm50368057
tiazofurina
unii-ulj82834re
ulj82834re ,
tiazofurine [inn]
tiazofurinum
tiazofurin [mi]
tiazofurine [who-dd]
SCHEMBL4287
FVRDYQYEVDDKCR-DBRKOABJSA-N
2-b-d-ribofuranosyl-4-thiazolecarboxamide
dibutylaminehydrochloride
2-(beta-d-ribofuranosyl)-4-thiazolecarboxamide
(1r)-1,4-anhydro-1-(4-carbamoyl-1,3-thiazol-2-yl)-d-ribitol
DTXSID00208827
2-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)thiazole-4-carboxamide
DB13243
BS-17271
Q7800305
mfcd00866494
C22196
W18798
HY-114570
CS-0063433

Research Excerpts

Overview

Tiazofurin (TZF) is a cytostatic drug that leads to depletion of the GTP pool in tumor and normal cells via its active metabolite. The drug has marked preclinical antitumor activity against P388 and L1210 leukemias, and the Lewis lung carcinoma.

ExcerptReferenceRelevance
"Tiazofurin (TZF) is a cytostatic drug that leads to depletion of the GTP pool in tumor and normal cells via its active metabolite tiazofurin-adenine dinucleotide (TAD). "( Erythrocytotoxicity of tiazofurin in vivo and in vitro detected by scanning probe microscopy.
Dimitrijević, B; Dramićanin, T; Jokanović, M; Jozanov-Stankov, O; Medić, L; Popov-Celeketić, D; Savovski, K; Subota, V; Vranić-Mandusić, V, 2004
)
2.08
"Tiazofurin is an interesting drug now entering Phase I trials, with marked preclinical antitumor activity against P388 and L1210 leukemias, and the Lewis lung carcinoma. "( Tiazofurin: a new antitumor agent.
Cooney, DA; Davignon, JP; Davis, RD; Jayaram, HN; Johns, DG; Malspeis, L; Marsoni, S; O'Dwyer, PJ; Plowman, J; Shoemaker, DD, 1984
)
3.15
"Tiazofurine is a selective inhibitor of the enzyme inosine monophosphate dehydrogenase, and exhibits potent antitumor activity. "( Tiazofurine uptake by the isolated guinea pig heart.
Jovanović, SS; Marković, ID; Mitrović, DM; Rakić, LM; Redzić, ZB; Rosić, MA, 1995
)
3.18
"Tiazofurin is a nucleoside analog with potent antitumor activity. "( Kinetics and sodium independence of [3H]-tiazofurin blood to brain transport in the guinea pig.
Gasic, JM; Jovanovic, SS; Markovic, ID; Mitrovic, DM; Rakic, LM; Redzic, ZB; Zlokovics, BV,
)
1.84
"Tiazofurine is a nucleoside analog with oncolytic activity being developed by Ribapharm (formerly ICN Pharmaceuticals) as a potential treatment for leukemia. "( Tiazofurine ICN Pharmaceuticals.
Grifantini, M, 2000
)
3.19
"Tiazofurin is an oncolytic nucleoside analog that has shown therapeutic activity in end-stage acute non-lymphocytic leukemia and in chronic granulocytic leukemia in blast crisis. "( Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
Jayaram, HN; Murayama, K; Pillwein, K; Weber, G; Zhen, W, 1992
)
1.99
"Tiazofurin is an oncolytic agent which has shown therapeutic activity in end-stage acute nonlymphocytic leukemia (ANLL) and blast crisis of chronic granulocytic leukemia (CGL-BC). "( Determination of thiazole-4-carboxamide adenine dinucleotide (TAD) levels in mononuclear cells of leukemic patients treated with tiazofurin.
Jayaram, HN; Weber, G; Zhen, W, 1991
)
1.93
"Tiazofurin is an effective inducer of the maturation of HL-60 promyelocytic leukemia cells, as monitored by increased phagocytic ability and the capacity to reduce nitroblue tetrazolium (NBT). "( Induction of the differentiation of synchronized HL-60 leukemia cells by tiazofurin.
Blair, OC; Carbone, R; Sartorelli, AC; Sokoloski, JA, 1989
)
1.95
"Tiazofurin is an experimental chemotherapeutic agent currently undergoing clinical evaluation. "( Reversible cerebral lesions associated with tiazofurin usage: MR demonstration.
Bognanno, JR; Boyko, OB; D'Amour, PG; Edwards, MK; Rippe, DJ; Schrodt, JF,
)
1.84
"Tiazofurin appears to be a promising agent in the treatment of leukemia because of its selective action on leukemic cells and the availability of a rapid in vitro method capable of predicting sensitivity of leukemic cells to the agent and monitoring its activity during treatment by measuring thiazole-4-carboxamide adenine dinucleotide and GTP concentrations."( Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute myeloid leukemia.
Hoffman, R; Jayaram, HN; Lapis, E; Nichols, CR; Pennington, K; Tricot, GJ; Weber, G, 1987
)
1.26
"Tiazofurin is a synthetic "C" nucleoside analogue with a promising spectrum of experimental antitumor activity and a relatively novel mechanism of action. "( Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
Harrison, SD; O'Dwyer, PJ; Trader, MW, 1986
)
2.02
"Tiazofurin is a novel C-nucleoside with significant antitumor activity in murine tumor models. "( Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluation.
Culham, CA; Hartshorn, JN; Haugh, LD; Krakoff, IR; McCormack, JJ; Newman, RA; Roberts, JD; Stewart, JA; Young, JA, 1987
)
2.06
"Tiazofurin may prove to be an effective chemotherapeutic agent in the treatment of ovarian cancer."( Action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assay.
DiSaia, PJ; Kucera, PR; Micha, JP; Preve, CU; Rettenmaier, MA; Stratton, JA, 1985
)
1.24

Actions

ExcerptReferenceRelevance
"Tiazofurin is known to inhibit inosine 5'-phosphate dehydrogenase (IMPDH), the rate limiting enzyme of de novo guanine ribonucleotide synthesis."( Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot, G; Weber, G,
)
1.06

Treatment

Tiazofurin treatment of K562 leukemia cells in vitro depletes the metabolites of the guanylate biosynthetic pathway, inducing erythroid differentiation. Treatment also stimulated [3H]deoxyguanosine utilization (8-fold) by HGPRTase-deficient cells.

ExcerptReferenceRelevance
"Tiazofurin treatment resulted in significant anti-tumor activity in rats inoculated with hepatoma 3924A."( Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
Faderan, MA; Jayaram, HN; Liepnieks, JJ; Lui, MS; Natsumeda, Y; Olah, E; Weber, G, 1984
)
1.22
"Tiazofurin treatment of K562 leukemia cells in vitro depletes the metabolites of the guanylate biosynthetic pathway, inducing erythroid differentiation, that, in turn, alters the phenotypic profile. "( Tiazofurin induces a down-modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing.
Bavelloni, A; Cataldi, A; Marmiroli, S; Vitale, M; Weber, G; Zamai, L; Zauli, G, 1995
)
3.18
"Tiazofurin treatment decreased Ras-GTP concentration in a time- and dose-dependent fashion."( Tiazofurin decreases Ras-GTP complex in K562 cells.
Hata, Y; Natsumeda, Y; Weber, G, 1993
)
2.45
"In tiazofurin-treated cells an intermediate pattern was found."( Apoptotic pathways depend on the target enzymatic activity and not on the triggering agent.
Cinti, C; Columbaro, M; Di Baldassarre, A; Falcieri, E; Luchetti, F; Mariani, AR,
)
0.65
"Tiazofurin treatment also stimulated [3H]deoxyguanosine utilization (8-fold) by HGPRTase-deficient cells, and accordingly, greatly increased the cytotoxicity of 2'-deoxy-3-deazaguanosine and arabinosylguanine."( Use of tiazofurin to enhance the metabolism and cytotoxic activities of analogues of guanine, guanosine, and deoxyguanosine.
Robins, RK; Saunders, PP; Spindler, CD; Tan, MT, 1987
)
1.45
"Treatment with tiazofurin, selenazofurin, or mycophenolic acid decreased guanylate pools and caused an accumulation of IMP in WIL2 human lymphoma cells."( Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
Berry, DA; Besserer, JA; Boritzki, TJ; Cook, PD; Fry, DW; Jackson, RC; Leopold, WR, 1985
)
0.88

Toxicity

ExcerptReferenceRelevance
" Since BR does exhibit myelosuppression, the most common chemotherapy-related side effect in humans, careful judgment is warranted should BR be included in multidrug regimens, although BR's potent cytotoxicity to tumor cells in preclinical models still makes it a promising drug."( Toxicity and efficacy of benzamide riboside in cancer chemotherapy models.
Arguello, F; Greene, JF; Jayaram, HN; Yalowitz, JA, 2002
)
0.31

Pharmacokinetics

A phase I and pharmacokinetic study of tiazofurin (NSC 286193), a C-nucleoside that inhibits IMP dehydrogenase has been completed.

ExcerptReferenceRelevance
" We present pharmacokinetic parameters of our clinical study and examine some of the reasons for the lower toxicity found in our trials."( Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion.
Engeler, GP; Hoffman, R; Jayaram, HN; Kneebone, P; Lapis, E; Paulik, E; Tricot, G; Weber, G; Zhen, W, 1992
)
0.56
"A phase I and pharmacokinetic study of tiazofurin (NSC 286193), a C-nucleoside that inhibits IMP dehydrogenase, has been completed."( Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion.
Bishop, J; Coates, A; Fox, R; Grygiel, J; Raghavan, D; Sampson, D; Woods, R, 1986
)
0.81
"The pharmacokinetic disposition of tiazofurin in plasma and cerebrospinal fluid was examined in rhesus monkeys."( Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys.
Balis, FM; Collins, JM; Grygiel, JJ; Lester, CM; Poplack, DG, 1985
)
0.87
" Tiazofurin levels were measured using a high-pressure liquid chromatography assay, and pharmacokinetic studies were performed in patients treated at each dose level."( Phase I evaluation and pharmacokinetics of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
Boldt, DH; Clark, GM; Hersh, MR; Kuhn, JG; Melink, TJ; Patton, TF; Siegler, R; Sternson, LA; Von Hoff, DD, 1985
)
1.44
"Human pharmacokinetic parameters are often predicted prior to clinical study from in vivo preclinical pharmacokinetic data."( Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Jolivette, LJ; Ward, KW, 2005
)
0.33
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" No objective remission was observed at the dosage of 800 mg/m2 for 5 consecutive days."( Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma.
Carr, DT; Dhingra, HM; Glisson, BS; Holoye, PY; Jeffries, D; Lee, JS; Murphy, WK; Umsawasdi, T, 1988
)
0.61
" We test new structures in 20 well-selected human tumor xenografts and in the P388 mouse leukemia in dose-response relationships."( Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.
Bieser, W; Fiebig, HH; Henss, H; Lohr, GW; Schmid, JR, 1987
)
0.27
" A definite relationship exists between dosage and steady-state levels."( Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion.
Bishop, J; Coates, A; Fox, R; Grygiel, J; Raghavan, D; Sampson, D; Woods, R, 1986
)
0.54
" In a dose-response study, injection of varying amounts of the drug decreased NAD pools in the hepatoma in a dose-dependent fashion."( Tiazofurin-induced selective depression of NAD content in hepatoma 3924A.
Faderan, MA; Liepnieks, JJ; Lui, MS; Weber, G, 1984
)
1.71
" Drug doses of 125 and 250 mg/kg on a day-1, -3 and -5 dosing schedule increased the life span (ILS) relative to untreated control mice of 36."( In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog.
La Colla, P; Manfredini, S; Marongiu, ME; Montis, AD; Pani, A; Perra, G; Pinna, E; Scintu, F,
)
0.13
" Ribavirin was given daily at a dosage of 30 mg/kg and tiazofurin was given at a dosage of 10 mg/kg every other day for 15 days."( Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
Bjelobaba, I; Dacic, S; Jovanovic, S; Lavrnja, I; Mostarica-Stojkovic, M; Nedeljkovic, N; Pekovic, S; Rakic, L; Stojiljkovic, M; Stojkov, D; Stosic-Grujicic, S, 2008
)
0.83
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
EC 1.1.1.205 (IMP dehydrogenase) inhibitorAn EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of IMP dehydrogenase (EC 1.1.1.205), so blocking de novo biosynthesis of purine nucleotides.
prodrugA compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
C-glycosyl compoundA glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a carbon atom, thus creating a C-C bond.
1,3-thiazoles
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alcohol dehydrogenase E chainEquus caballus (horse)Ki10,000.00000.14122.89278.7000AID33858
Alcohol dehydrogenase S chainEquus caballus (horse)Ki10,000.00000.14122.89278.7000AID33858
Metabotropic glutamate receptor 3Rattus norvegicus (Norway rat)Ki10,000.00000.00300.13400.4760AID74662
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (3)

Processvia Protein(s)Taxonomy
glutamate catabolic processGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
glutamine metabolic processGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
tricarboxylic acid metabolic processGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
glutamate dehydrogenase (NAD+) activityGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
glutamate dehydrogenase [NAD(P)+] activityGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
glutamate dehydrogenase (NADP+) activityGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
ATP bindingGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
GTP bindingGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
identical protein bindingGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
mitochondrionGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
mitochondrial inner membraneGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
endoplasmic reticulumGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (345)

Assay IDTitleYearJournalArticle
AID1610087Induction of apoptosis in human K562 cells assessed as reduction in cell membrane integrity at cytotoxic IC50 incubated for 72 hrs by acridine orange and ethidium bromide double staining based fluorescence microscopy2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID120504Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 25 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1283858Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID98926Inhibitory concentration against L1210 murine lymphocytic leukemia1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID694969Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID291118Cytotoxicity against human HL60 cell line after 48 hrs by MTT assay2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
AID1283888Induction of apoptosis in human K562 cells assessed as caspase 3 level after 72 hrs by Western blotting method (Rvb = 17.05%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID118959Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 200 mg/kg in experiment 1; No deaths1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95980Compound was tested for its effect on NAD ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID118974Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 50 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID124328Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 400 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID118966Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 3.12 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1610060Antiproliferative activity against human K562 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID88522Compound was tested for antiproliferative activity against HeLa, human cervix carcinoma1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID119101Mice were inoculated intraperitoneally with L1210 leukemia cells and the median life span of the mice with the compound was evaluated at a dose of 25 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID9872Compound was tested for antiproliferative activity against ACHN, human renal adenocarcinoma1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID540218Clearance in monkey after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID124188Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 100 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID152552The influence (5000 uM) on Guanine nucleotide pools of Natural P388 resistant cell lines measured as conc. of GTP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID118955Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 100 mg/kg in experiment 3; No deaths1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1079949Proposed mechanism(s) of liver damage. [column 'MEC' in source]
AID124187Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 1.56 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1135405Antiviral activity against type 1 parainfluenza virus infected in mouse assessed as mouse survival at 104 mg/kg, po thrice a day for 8 days after 1 hr viral infection1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID95814Compound was tested for its effect on CDP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID124334Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 6.25 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID118952Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 1.56 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID124195Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 200 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID120508Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 3.12 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID152535The influence (2.5 uM) on Guanine nucleotide pools of Natural P388 resistant cell lines measured as conc. of GDP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID264053Antiproliferative activity against human HeLa cell line2006Bioorganic & medicinal chemistry letters, May-15, Volume: 16, Issue:10
Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities.
AID152714Evaluated for cytotoxicity against L1210 cells1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Synthesis and antitumor activity of 2-beta-D-ribofuranosylselenazole-4- carboxamide and related derivatives.
AID95785Differentiation of K-562 cells at 19 uM with coadministration of guanosine1997Journal of medicinal chemistry, Apr-11, Volume: 40, Issue:8
The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).
AID98672Evaluated for cytotoxicity against L1210 cells1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Synthesis and antitumor activity of 2-beta-D-ribofuranosylselenazole-4- carboxamide and related derivatives.
AID1135401Antiviral activity against type 1 herpes simplex virus type 1 infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID124190Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 100 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID274147Cytotoxicity against HT29 cells after 24 hrs by MTT assay2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
AID1079938Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]
AID124321Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 25 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID540219Volume of distribution at steady state in monkey after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID223482Compound was tested for ratio of survival time of treated to control mice x100 at 25 mg/kg dose1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID694972Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID120621Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 400 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID124194Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 200 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1079941Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]
AID120505Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 25 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID120623Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 400 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1610063Antiproliferative activity against human Raji cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1079935Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]
AID120630Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 800 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID221910Mice were inoculated intraperitoneally with L1210 leukemia cells and the median life span of the mice with the compound was evaluated at a dose of 100 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID291121Cytotoxicity against human HT29 cell line after 48 hrs by MTT assay2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
AID94824The ability to induce differentiation in K562 cells was estimated by determining the fraction of benzidine positive cells converted following incubation with the compound.1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.
AID118953Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 100 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1283871Induction of specific apoptosis in human K562 cells after 72 hrs by annexin V-FITC/propidium iodide staining based flow cytometry2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID1610097Cell cycle arrest in human K562 cells assessed as accumulation in S phase incubated for 24 hrs by propidium iodide staining based flow cytometry (Rvb = 48.38%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID152540The influence (2.5 uM) on Guanine nucleotide pools of Natural P388 sensitive cell lines measured as conc. of GTP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID95960Compound was tested for its effect on GDP ribonucleotide levels of K562 cell at 50u1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID95780Compound was tested for its effect on IMPDH activity against K562 cells at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1610086Induction of apoptosis in human K562 cells assessed as 85 kDa PARP level incubated for 72 hrs by Western blot analysis (Rvb = 100%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID95970Compound was tested for its effect on GTP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1283889Induction of apoptosis in human K562 cells assessed as cleaved PARP level after 72 hrs by Western blotting method (Rvb = 18.36%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID1135414Antiviral activity against type 1 parainfluenza virus infected in mouse assessed as mouse mean death day at 104 mg/kg, po thrice a day for 8 days after 1 hr viral infection (Rvb = 8.9 days)1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID1283874Induction of apoptosis in human K562 cells assessed as necrotic cells after 24 hrs by annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 1.50%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID116421Mice were inoculated intraperitoneally with L1210 leukemia cells and the percentage ILS of the mice with the compound was evaluated at a dose of 50 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID1135399Inhibition of purine nucleotide biosynthesis in mouse Ehrlich ascites tumor cells assessed as inhibition of [14C]hypoxanthine into adenine nucleotides at 1 mM after 60 mins incubation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID694960Cytotoxicity against human MCF7 cells2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID152539The influence (2.5 uM) on Guanine nucleotide pools of Natural P388 sensitive cell lines measured as conc. of GMP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID1610084Induction of apoptosis in human K562 cells assessed as 18 kDa Caspase 3 active subunit level incubated for 72 hrs by Western blot analysis (Rvb = 100%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1283864Induction of cell cycle arrest in human K562 cells assessed as accumulation at G0/G1 phase after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 36.28%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID120626Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 50 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95804Compound was tested for its effect on AMP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID120503Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 200 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID96000compound was tested for its effect on IMPDH activity against K562 cells at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID39253Inhibitory concentration against B16 melanoma cell lines1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID120506Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 25 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID694958Induction of apoptosis in human K562 cells at IC50 concentration after 24 hrs by AnnexinV staining-based flow cytometric analysis2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID45415Compound was tested for antiproliferative activity against CHO-K1, Chinese hamster ovary cells1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID227349Compound tested for the inhibition of IMP-dehydrogenase causing a profound depletion of GMP anf accumulation of IMP; Active1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
Synthesis of 5-beta-D-ribofuranosylnicotinamide and its N-methyl derivative. The isosteric and isoelectronic analogues of nicotinamide nucleoside.
AID89224Compound was evaluated for inhibitory concentration potent against IMPDH type-II1996Journal of medicinal chemistry, Jun-07, Volume: 39, Issue:12
Chemical synthesis of benzamide adenine dinucleotide: inhibition of inosine monophosphate dehydrogenase (types I and II).
AID152538The influence (2.5 uM) on Guanine nucleotide pools of Natural P388 sensitive cell lines measured as conc. of GDP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID112422Compound was evaluated for the cytotoxicity to L1210 leukemia cells in culture at ~1.6-fold higher concentrations and expressed as ID501984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID1283870Induction of specific apoptosis in human K562 cells after 24 hrs by annexin V-FITC/propidium iodide staining based flow cytometry2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID95996Inhibition of growth in human erythroleukemia K-562 cells (% of untreated control)1997Journal of medicinal chemistry, Apr-11, Volume: 40, Issue:8
The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).
AID95992Compound was tested for its effect on UTP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1079948Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]
AID124333Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 50 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95995Compound was tested for its effect on UTP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID199875Virus rating against rhinovirus type 1A1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure.
AID672935Growth inhibition of human PC3 cells at 500 uM2012Bioorganic & medicinal chemistry letters, Aug-15, Volume: 22, Issue:16
Novel synthetic route to the C-nucleoside, 2-deoxy benzamide riboside.
AID120494Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 1.56 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1610064Antiproliferative activity against human HT-29 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID94650Formation of NAD analogue by compound at 50 uM concentration against human myelogenous leukemia K5621995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1610075Cell cycle arrest in human K562 cells assessed as accumulation in G2/M phase incubated for 72 hrs by propidium iodide staining based flow cytometry (Rvb = 15.45%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1283860Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID34142Virus rating against adenovirus type 21989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure.
AID229260Ratio of IC50 against HL-601995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1610085Induction of apoptosis in human K562 cells assessed as 112 kDa PARP level incubated for 72 hrs by Western blot analysis (Rvb = 100%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1283872Induction of specific necrosis in human K562 cells after 24 hrs by annexin V-FITC/propidium iodide staining based flow cytometry2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID106791In vitro inhibitory activity against pig heart cytoplasmic malate dehydrogenase (MDH); No data1990Journal of medicinal chemistry, Apr, Volume: 33, Issue:4
Dehydrogenase binding by tiazofurin anabolites.
AID1610076Cell cycle arrest in human K562 cells assessed as accumulation in S phase incubated for 72 hrs by propidium iodide staining based flow cytometry (Rvb = 36.05%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID124186Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 0.78 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID96164Inhibitory concentration against K562 human myelogenous leukemia cell line1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID118973Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 50 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1283883Induction of apoptosis in human K562 cells assessed as Bax protein level after 24 hrs by Western blotting method (Rvb = 16.13%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID150671Inhibitory concentration against P388 murine lymphocytic leukemia cell lines1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID120627Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 6.25 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1610059Induction of apoptosis in human K562 cells incubated for 24 hrs by annexin V FITC and propidium iodide staining based flow cytometry relative to control2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID229951IC50 ratio against bone marrow samples to HL-601995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID94624Compound was tested for its influence on the GDP (Glucose diphosphate) ribonucleotide level in K562 cells1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID120624Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 50 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID116420Mice were inoculated intraperitoneally with L1210 leukemia cells and the percentage ILS of the mice with the compound was evaluated at a dose of 400 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID95801Compound was tested for its effect on AMP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID694971Cytotoxicity against human K562 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID95962Compound was tested for its effect on GMP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1610061Antiproliferative activity against human HL60 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1283878Induction of apoptosis in human K562 cells assessed as necrotic cells after 72 hrs by annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 7.23%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID540217Volume of distribution at steady state in dog after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID1079937Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]
AID1283877Induction of apoptosis in human K562 cells assessed as early apoptotic cells after 24 hrs by annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 8.09%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID118962Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 25 mg/kg in experiment 1; No deaths1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95975Compound was tested for its effect on IMP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID264050Antiproliferative activity against human HL60 cell line2006Bioorganic & medicinal chemistry letters, May-15, Volume: 16, Issue:10
Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities.
AID1283862Induction of cell cycle arrest in human K562 cells assessed as accumulation at Sub-G1 phase after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 1.05%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID91399Compound was tested for its inhibition against IMPDH from human myelogenous leukemia K562 cells in culture.1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID222821Average weight change of mice from onset to termination of drug treatment at 25 mg/kg dose1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID694961Cytotoxicity against human MDA-MB-231 cells2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID152543The influence (5 uM) on Guanine nucleotide pools of Natural P388 sensitive cell lines measured as conc. of GTP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID1610089Induction of necrosis in human K562 cells incubated for 24 hrs by annexin V FITC and propidium iodide staining based flow cytometry relative to control2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID33858In vitro inhibitory activity against horse liver Alcohol dehydrogenase1990Journal of medicinal chemistry, Apr, Volume: 33, Issue:4
Dehydrogenase binding by tiazofurin anabolites.
AID94794Compound was tested for antiproliferative activity against K562, human erythroid leukemia1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID95982Compound was tested for its effect on UDP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID120625Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 50 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID228485Percentage of benzidine positive cells is divided by the concentration used.1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.
AID1079931Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]
AID95816Compound was tested for its effect on CTP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID103558Concentration required to inhibit MCF-7 cell growth2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties.
AID87045Virus rating of against herpes simplex virus type 21989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure.
AID81483Inhibitory concentration against HL-60 human promyelocytic leukemia1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID95786Differentiation of K-562 cells at 19 uM with out coadministration of guanosine1997Journal of medicinal chemistry, Apr-11, Volume: 40, Issue:8
The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).
AID91397Compound was tested for its effect on IMPDH (Inosine 5`-monophosphate dehydrogenase) activity of K562 cells in culture.1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID118971Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 400 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID264054Antiproliferative activity against human MRC5 cell line2006Bioorganic & medicinal chemistry letters, May-15, Volume: 16, Issue:10
Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities.
AID124331Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 50 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID694967Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID124336Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 800 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID119104Mice were inoculated intraperitoneally with L1210 leukemia cells and the median life span of the mice with the compound was evaluated at a dose of 800 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID120497Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 100 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID118970Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 400 mg/kg in experiment 2; No deaths1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1135400Inhibition of purine nucleotide biosynthesis in mouse Ehrlich ascites tumor cells assessed as inhibition of [14C]hypoxanthine into guanine nucleotides at 1 mM after 60 mins incubation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID1283857Antiproliferative activity against human Raji cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID94797Concentration required to inhibit K562 cell growth2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties.
AID274148Cytotoxicity against HeLa cells after 24 hrs by MTT assay2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
AID1610066Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1283861Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID1610099Cell cycle arrest in human K562 cells assessed as accumulation in sub-G1 phase incubated for 24 hrs by propidium iodide staining based flow cytometry (Rvb = 1.05%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID124337Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 800 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID110281Mice were inoculated intraperitoneally with L1210 leukemia cells and the change in body weight of the mice with the compound was evaluated at a dose of 200 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID120495Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 100 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1283880Induction of apoptosis in human K562 cells assessed as living cells after 72 hrs by annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 84.31%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID92756Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 2 (IMPDH type II); NA is not active2002Journal of medicinal chemistry, Jan-31, Volume: 45, Issue:3
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
AID118956Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 12.5 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID94625Compound was tested for its influence on the GMP (Glucose monophosphate) ribonucleotide level in K562 cells1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID1283885Induction of apoptosis in human K562 cells assessed as cleaved PARP level after 24 hrs by Western blotting method (Rvb = 36.17%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID120493Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 0.78 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1610078Cell cycle arrest in human K562 cells assessed as accumulation in SubG1 phase incubated for 72 hrs by propidium iodide staining based flow cytometry (Rvb = 3.07%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1610062Antiproliferative activity against human Jurkat cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID95990Compound was tested for its effect on UMP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID540216Clearance in dog after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID74662In vitro inhibitory activity against bovine liver glutamate dehydrogenase (GDH)1990Journal of medicinal chemistry, Apr, Volume: 33, Issue:4
Dehydrogenase binding by tiazofurin anabolites.
AID110282Mice were inoculated intraperitoneally with L1210 leukemia cells and the change in body weight of the mice with the compound was evaluated at a dose of 25 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID1283867Induction of cell cycle arrest in human K562 cells assessed as accumulation at S phase after 72 hrs by propidium iodide staining-based flow cytometry (Rvb = 35.73%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID223483Compound was tested for ratio of survival time of treated to control mice x100 at 400 mg/kg dose1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID274145Cytotoxicity against human K562 cells after 24 hrs by MTT assay2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
AID1283868Induction of cell cycle arrest in human K562 cells assessed as accumulation at G2/M phase after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 14.29%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID95811Compound was tested for its effect on CDP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1610080Induction of necrosis in human K562 cells incubated for 72 hrs by annexin V FITC and propidium iodide staining based flow cytometry relative to control2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1135416Antiviral activity against type 1 parainfluenza virus infected in mouse assessed as mouse mean death day at 26 mg/kg, po thrice a day for 8 days after 1 hr viral infection (Rvb = 8.9 days)1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID95967Compound was tested for its effect on GTP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID43684Compound was tested for antiproliferative activity against CCRF-CEM, human acute T-lymphoblastic leukemia1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID124323Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 25 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1283886Induction of apoptosis in human K562 cells assessed as Bcl2 protein level after 72 hrs by Western blotting method (Rvb = 7.90%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID120498Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 12.5 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID694959Cytotoxicity against human HT-29 cells2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID81472In vitro inhibitory activity against HL-60 human promyelocytic leukemia cells1990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Synthesis and antitumor activity of 2-beta-D-ribofuranosyloxazole-4-carboxamide (oxazofurin).
AID124189Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 100 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95821Compound was tested for its effect on GDP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1283873Induction of specific necrosis in human K562 cells after 72 hrs by annexin V-FITC/propidium iodide staining based flow cytometry2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID95806Compound was tested for its effect on ATP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID120496Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 100 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1610088Genotoxicity in human K562 cells assessed as increase in DNA damage at cytotoxic IC50 incubated for 72 hrs by comet assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID118842Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 0.78 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID81451Concentration required to inhibit HL-60 cell growth2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties.
AID116422Mice were inoculated intraperitoneally with L1210 leukemia cells and the percentage ILS of the mice with the compound was evaluated at a dose of 800 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID1610083Induction of apoptosis in human K562 cells assessed as 32 kDa Caspase 3 precursor level incubated for 72 hrs by Western blot analysis (Rvb = 100%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1610077Cell cycle arrest in human K562 cells assessed as accumulation in G0/G1 phase incubated for 72 hrs by propidium iodide staining based flow cytometry (Rvb = 45.43%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1283859Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID1079947Comments (NB not yet translated). [column 'COMMENTAIRES' in source]
AID95470Compound effect on differentiation of K562 cells, % of benzidine positive cells at 1.0 uM2002Journal of medicinal chemistry, Jan-31, Volume: 45, Issue:3
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
AID120629Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 800 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95799Compound was tested for its effect on ADP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID124324Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 25 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID118960Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 200 mg/kg in experiment 2; No deaths1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID124320Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 200 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID540220Clearance in human after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID291120Cytotoxicity against human Raji cells after 48 hrs by MTT assay2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
AID1610065Antiproliferative activity against human HeLa cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID92611Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 1 (IMPDH type I); NA is not active2002Journal of medicinal chemistry, Jan-31, Volume: 45, Issue:3
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
AID1283855Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID1610094Cell cycle arrest in human K562 cells assessed as accumulation in G2/M phase incubated for 24 hrs by propidium iodide staining based flow cytometry (Rvb = 14.29%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1283866Induction of cell cycle arrest in human K562 cells assessed as accumulation at S phase after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 48.38%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID1135403Antiviral activity against type 13 rhinovirus infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID118964Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 25 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID105295Compound was tested for antiproliferative activity against MOLT-4, human acute T-lymphoblastic leukemia1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID1283854Antiproliferative activity against human K562 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID124325Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 3.12 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95977Compound was tested for its effect on NAD ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID694966Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID98757In vitro inhibitory activity against L1210 murine lymphocytic leukemia cells1990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Synthesis and antitumor activity of 2-beta-D-ribofuranosyloxazole-4-carboxamide (oxazofurin).
AID1079939Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]
AID124330Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 400 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID264049Antiproliferative activity against human K562 cell line2006Bioorganic & medicinal chemistry letters, May-15, Volume: 16, Issue:10
Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities.
AID124332Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 50 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID120631Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 800 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID94653Antiproliferative activity against K562 erythroid leukemic cells was determined.1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.
AID1079940Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]
AID1283865Induction of cell cycle arrest in human K562 cells assessed as accumulation at G0/G1 phase after 72 hrs by propidium iodide staining-based flow cytometry (Rvb = 45.92%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID152541The influence (5 uM) on Guanine nucleotide pools of Natural P388 sensitive cell lines measured as conc. of GDP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID110283Mice were inoculated intraperitoneally with L1210 leukemia cells and the change in body weight of the mice with the compound was evaluated at a dose of 400 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID1283856Antiproliferative activity against human Jurkat cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID83582Concentration required to inhibit HT-29 cell growth2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties.
AID1283887Induction of apoptosis in human K562 cells assessed as Bax protein level after 72 hrs by Western blotting method (Rvb = 32.81%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID94649Formation of NAD analogue by compound at 100 uM concentration against human myelogenous leukemia K5621995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID118954Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 100 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID291123Cytotoxicity against human MRC5 cell line after 48 hrs by MTT assay2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
AID116418Mice were inoculated intraperitoneally with L1210 leukemia cells and the percentage ILS of the mice with the compound was evaluated at a dose of 200 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID95788Differentiation of K-562 cells at 3.8 uM with out coadministration of guanosine1997Journal of medicinal chemistry, Apr-11, Volume: 40, Issue:8
The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1079946Presence of at least one case with successful reintroduction. [column 'REINT' in source]
AID1283879Induction of apoptosis in human K562 cells assessed as late apoptotic cells after 72 hrs by annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 5.24%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID105991Concentration required to inhibit MRC-5 cell growth2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties.
AID1283882Induction of apoptosis in human K562 cells assessed as Bcl2 protein level after 24 hrs by Western blotting method (Rvb = 22.81%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID86105Compound was tested for antiproliferative activity against HT29, human colon adenocarcinoma1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID95819Compound was tested for its effect on CTP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID291122Cytotoxicity against human MCF7 cell line after 48 hrs by MTT assay2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
AID540214Clearance in rat after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID120502Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 200 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID94626Compound was tested for its influence on the GTP (Glucose triphosphate) ribonucleotide level in K562 cells1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID102181Inhibitory concentration against LoVo human colon adenocarcinoma cell lines1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID118978Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 800 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1079944Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]
AID110285Mice were inoculated intraperitoneally with L1210 leukemia cells and the change in body weight of the mice with the compound was evaluated at a dose of 800 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID1283869Induction of cell cycle arrest in human K562 cells assessed as accumulation at G2/M phase after 72 hrs by propidium iodide staining-based flow cytometry (Rvb = 15.31%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID110280Mice were inoculated intraperitoneally with L1210 leukemia cells and the change in body weight of the mice with the compound was evaluated at a dose of 100 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID1283876Induction of apoptosis in human K562 cells assessed as living cells after 24 hrs by annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 85.85%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID1079934Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]
AID118972Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 50 mg/kg in experiment 1; No deaths1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95987Compound was tested for its effect on UMP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID95787Differentiation of K-562 cells at 3.8 uM with coadministration of guanosine1997Journal of medicinal chemistry, Apr-11, Volume: 40, Issue:8
The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).
AID1135402Antiviral activity against type 3 herpes simplex virus infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID1079936Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]
AID120501Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 200 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID219233Compound was tested for antiproliferative activity against Wil2-NS, human splenic lymphoblastoid cells1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID165775Compound was tested for antiproliferative activity against Raji, human Burkitt lymphoma1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID1283875Induction of apoptosis in human K562 cells assessed as late apoptotic cells after 24 hrs by annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 4.58%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID116417Mice were inoculated intraperitoneally with L1210 leukemia cells and the percentage ILS of the mice with the compound was evaluated at a dose of 100 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID95965Compound was tested for its effect on GMP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID39132In vitro inhibitory activity against B16 murine melanoma cells1990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Synthesis and antitumor activity of 2-beta-D-ribofuranosyloxazole-4-carboxamide (oxazofurin).
AID152550The influence (5000 uM) on Guanine nucleotide pools of Natural P388 resistant cell lines measured as conc. of GDP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID95797Compound was tested for its effect on ADP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID120622Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 400 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID118975Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 6.25 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95478Compound effect on differentiation of K562 cells, % of benzidine positive cells at 15 uM2002Journal of medicinal chemistry, Jan-31, Volume: 45, Issue:3
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
AID1610081Induction of apoptosis in human K562 cells assessed as Bcl2 level incubated for 72 hrs by Western blot analysis (Rvb = 100%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID1079932Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]
AID1135415Antiviral activity against type 1 parainfluenza virus infected in mouse assessed as mouse mean death day at 52 mg/kg, po thrice a day for 8 days after 1 hr viral infection (Rvb = 8.9 days)1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID94622The concentration used to induce differentiation in K562 cells1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.
AID540215Volume of distribution at steady state in rat after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID1283884Induction of apoptosis in human K562 cells assessed as caspase 3 level after 24 hrs by Western blotting method (Rvb = 42.77%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID95985Compound was tested for its effect on UDP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1610098Cell cycle arrest in human K562 cells assessed as accumulation in G0/G1 phase incubated for 24 hrs by propidium iodide staining based flow cytometry (Rvb = 36.28%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID694970Cytotoxicity against human Raji cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
AID152551The influence (5000 uM) on Guanine nucleotide pools of Natural P388 resistant cell lines measured as conc. of GMP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID124191Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 12.5 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1079943Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]
AID1135409Toxicity in mouse assessed as survival at 104 mg/kg, po1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis and antiviral activity of certain thiazole C-nucleosides.
AID229974IC90 ratio against bone marrow samples to HL-601995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID152542The influence (5 uM) on Guanine nucleotide pools of Natural P388 sensitive cell lines measured as conc. of GMP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID7221Compound was tested for antiproliferative activity against 5637, human bladder carcinoma cell line1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID1283863Induction of cell cycle arrest in human K562 cells assessed as accumulation at Sub-G1 phase after 72 hrs by propidium iodide staining-based flow cytometry (Rvb = 3.04%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID222822Average weight change of mice from onset to termination of drug treatment at 400 mg/kg dose1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID124322Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 25 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID1283881Induction of apoptosis in human K562 cells assessed as early apoptotic cells after 72 hrs by annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 3.22%)2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
AID291119Cytotoxicity against human Jurkat T cells after 48 hrs by MTT assay2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
AID264052Antiproliferative activity against human MCF7 cell line2006Bioorganic & medicinal chemistry letters, May-15, Volume: 16, Issue:10
Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities.
AID118965Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 25 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID152537The influence (2.5 uM) on Guanine nucleotide pools of Natural P388 resistant cell lines measured as conc. of GTP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID116419Mice were inoculated intraperitoneally with L1210 leukemia cells and the percentage ILS of the mice with the compound was evaluated at a dose of 25 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID274146Cytotoxicity against Jurkat cells after 24 hrs by MTT assay2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
AID118979Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 800 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID96171Tested for inhibition of growth in human erythroleukemia K-562 cells.1997Journal of medicinal chemistry, Apr-11, Volume: 40, Issue:8
The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).
AID81642Inhibitory concentration range against human HL-60 cell line1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID124338Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 800 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID94627Compound was tested for its influence on the IMP (Inosine 5`-monophosphate) ribonucleotide level in K562 cells1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID1610082Induction of apoptosis in human K562 cells assessed as Bax level incubated for 72 hrs by Western blot analysis (Rvb = 100%)2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID81485Inhibitory concentration range against human HL-60 cell line1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1079933Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is
AID274149Cytotoxicity against MRC5 cells after 24 hrs by MTT assay2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
AID119100Mice were inoculated intraperitoneally with L1210 leukemia cells and the median life span of the mice with the compound was evaluated at a dose of 200 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID152536The influence (2.5 uM) on Guanine nucleotide pools of Natural P388 resistant cell lines measured as conc. of GMP1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis.
AID118961Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 200 mg/kg in experiment 31982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID291117Cytotoxicity against human K562 cells after 48 hrs by MTT assay2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
AID118969Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 400 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID342524Inhibition of IMP dehydrogenase2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.
AID119102Mice were inoculated intraperitoneally with L1210 leukemia cells and the median life span of the mice with the compound was evaluated at a dose of 400 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID90124Inhibitory concentration range against human bone marrow1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID98382Compound was tested for antiproliferative activity against L1210, murine lymphocytic leukemia1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID540221Volume of distribution at steady state in human after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID90123Inhibitory concentration range against human bone marrow1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID89223Compound was evaluated for inhibitory concentration potent against IMPDH type-I1996Journal of medicinal chemistry, Jun-07, Volume: 39, Issue:12
Chemical synthesis of benzamide adenine dinucleotide: inhibition of inosine monophosphate dehydrogenase (types I and II).
AID264051Antiproliferative activity against human HT29 cell line2006Bioorganic & medicinal chemistry letters, May-15, Volume: 16, Issue:10
Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities.
AID99369In vitro inhibitory activity against pig heart lactate dehydrogenase (LDH); No data1990Journal of medicinal chemistry, Apr, Volume: 33, Issue:4
Dehydrogenase binding by tiazofurin anabolites.
AID95607Concentration of the Antiproliferative compound required for the 50% inhibition of Growth against K562 cells2002Journal of medicinal chemistry, Jan-31, Volume: 45, Issue:3
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
AID1079945Animal toxicity known. [column 'TOXIC' in source]
AID120507Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 25 mg/kg in experiment 41982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID150542In vitro inhibitory activity against P388 murine lymphocytic leukemia cells1990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Synthesis and antitumor activity of 2-beta-D-ribofuranosyloxazole-4-carboxamide (oxazofurin).
AID44368Compound was tested for antiproliferative activity against CCRF-SB, human acute B-lymphoblastic leukemia1997Journal of medicinal chemistry, May-23, Volume: 40, Issue:11
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
AID119103Mice were inoculated intraperitoneally with L1210 leukemia cells and the median life span of the mice with the compound was evaluated at a dose of 50 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID118977Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 800 mg/kg in experiment 11982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID124329Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 400 mg/kg in experiment 21982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95972Compound was tested for its effect on IMP ribonucleotide levels of K562 cell at 100 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1079942Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]
AID100222Inhibitory concentration against LLC Lewis lung carcinoma1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID1610079Induction of apoptosis in human K562 cells incubated for 72 hrs by annexin V FITC and propidium iodide staining based flow cytometry relative to control2019European journal of medicinal chemistry, Dec-01, Volume: 183Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
AID118963Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 25 mg/kg in experiment 2; No deaths1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
AID95809Compound was tested for its effect on ATP ribonucleotide levels of K562 cell at 50 uM concentration1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID110284Mice were inoculated intraperitoneally with L1210 leukemia cells and the change in body weight of the mice with the compound was evaluated at a dose of 50 mg/kg1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
AID155596Virus rating against parainfluenza virus type 31989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (280)

TimeframeStudies, This Drug (%)All Drugs %
pre-199097 (34.64)18.7374
1990's103 (36.79)18.2507
2000's69 (24.64)29.6817
2010's10 (3.57)24.3611
2020's1 (0.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.13 (24.57)
Research Supply Index5.74 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (1.97%)5.53%
Reviews27 (8.85%)6.00%
Case Studies2 (0.66%)4.05%
Observational0 (0.00%)0.25%
Other270 (88.52%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]